Aurum PropTech Limited has scheduled an earnings call to update stakeholders on its financial performance for the quarter ended June 30, 2026. The conference will take place on July 21, 2026, at 4:00 PM IST via digital means. This disclosure was made to the stock exchanges in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The earnings call, titled "Leading the AI era of PropTech Q1/FY 2026-2027", will provide insights into the company's operational results for Q1 FY27. Senior management will lead the discussion, and participants are required to join through a supported web browser and enable microphone access for the Q&A session.

Management Representation

The following executives from Aurum PropTech will participate in the conference:

Conference Details

Attendees can join the session by clicking the participant link and entering their credentials. The platform allows participants to raise questions during the designated Q&A segment.

Aurum Proptech has scheduled a meeting of its Board of Directors for Thursday, July 16, 2026, to consider a proposal for raising capital. The board will evaluate the issuance of equity shares or other eligible securities through permissible modes, including private placement, qualified institutions placement, or preferential issue. The fundraising initiative is subject to required regulatory and statutory approvals as well as shareholder consent.

The company disclosed this information in a filing submitted to the stock exchanges on July 13, 2026. The notification was made pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

To facilitate the fundraising proposal, the Board will also consider convening an Extraordinary General Meeting or conducting a postal ballot. This process is intended to secure the approval of the shareholders regarding the capital raise and any necessary amendments to the company's constitutional documents.

The proposed fundraising will involve the issuance of securities through a combination of methods as permitted under applicable laws. The specific quantum of funds and the final pricing details were not disclosed in the regulatory filing.

The meeting agenda highlights the company's intent to leverage various capital-raising instruments to bolster its financial resources. The outcome of the board meeting and the subsequent shareholder approval process will determine the final structure and timing of the issue.